{"id":117,"date":"2018-01-08T11:39:03","date_gmt":"2018-01-08T11:39:03","guid":{"rendered":"http:\/\/confolab.sav.sk\/ovsb\/?page_id=117"},"modified":"2025-08-04T14:19:36","modified_gmt":"2025-08-04T14:19:36","slug":"ukoncene-projekty","status":"publish","type":"page","link":"https:\/\/confolab.sav.sk\/ovsb\/projekty\/ukoncene-projekty\/","title":{"rendered":"Ukon\u010den\u00e9 projekty"},"content":{"rendered":"\n\"image\"<\/a><\/td>\nERA-CVD_JTC2019-055
\nHF-MetaB – Metabolick\u00e1 terapia srdcov\u00e9ho zlyhania: \u00faloha vitam\u00ednov B<\/a> <\/em>(2020 \u2013 2024)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1 ml.<\/a><\/td>\n<\/tr>\n

2017-2022<\/h2>\n\n\n\n\n\n\n\n\n\n\n
<\/td>\n\n

Zahrani\u010dn\u00e9\/medzin\u00e1rodn\u00e9 granty:<\/h3>\n<\/td>\n<\/tr>\n

\"mito\"<\/a><\/td>\nEuropean Joint Program for Rare Diseases (EJP-RD) No 40-46300-98-1074
\nGrantov\u00e9 finan\u010dn\u00e9 zabezpe\u010denie symp\u00f3zia SIRMAMTHERA\u201922 \u2013 Mitochondria-associated membranes as a therapeutic target in rare neurodegenerative diseases <\/i><\/a> (26.-27. 10. 2022)
\nVed\u00faci projektu: Michal Cagalinec<\/a><\/td>\n<\/tr>\n
\"image\"<\/a><\/td>\nJRP\/2019\/836\/RyRinHeart
\nRyRinHeart – V\u00fdvoj inhib\u00edtorov ryanod\u00ednov\u00e9ho receptora pre srdcov\u00e9 ochorenia<\/a> <\/em>(2020 \u2013 2022)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1<\/a><\/td>\n<\/tr>\n
\"mito\"<\/a><\/td>\nSASPRO 0063\/01\/02
\nFunk\u010dn\u00e9 prepojenie mitochondri\u00ed a endoplazmatick\u00e9ho retikula u Wolframovho syndr\u00f3mu: predpokladan\u00fd v\u00fdznam pre ochranu mozgu a srdca <\/i><\/a> (2015-2018)
\nVed\u00faci projektu: Michal Cagalinec<\/a><\/td>\n<\/tr>\n
<\/td>\n\n

Agent\u00fara na podporu v\u00fdskumu a v\u00fdvoja (APVV):<\/h3>\n<\/td>\n<\/tr>\n

\"image\"<\/a><\/td>\nAPVV-16-0452
\nPPIS – Regul\u00e1cia pericelul\u00e1rnej proteol\u00fdzy: od molekul\u00e1rnych mechanizmov k nov\u00fdm subsetom imunitn\u00fdch buniek a terapeutick\u00fdm n\u00e1strojom<\/a><\/em> (2017-2021)
\nVed\u00faci projektu (\u00daMB SAV): Vladim\u00edr Leksa
\nVed\u00faci projektu za BMC SAV: Alexandra Zahradn\u00edkov\u00e1 ml.<\/a><\/td>\n<\/tr>\n
\"image\"<\/a><\/td>\nAPVV-15-0302
\nCAMYS \u2013 Cytoarchitekt\u00fara v\u00e1pnikovej signaliz\u00e1cie srdcov\u00fdch myocytov vo v\u00fdvoji hypertrofie myokardu<\/a> <\/em>(2016 \u2013 2019)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1<\/a><\/td>\n<\/tr>\n
\"membranes\"<\/a><\/td>\nAPVV-SK-FR-2015-0007
\nVplyv stresu endoplazmatick\u00e9ho retikula na ultra\u0161trukt\u00faru a metabolizmus kardiomyocytov cicavcov <\/em><\/a>(2016 \u2013 2017)<\/em>
\nVed\u00faci projektu: Marta Novotov\u00e1<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n
<\/td>\n\n

Vedeck\u00e1 grantov\u00e1 agent\u00fara M\u0160VVa\u0160 a SAV (VEGA):<\/h3>\n<\/td>\n<\/tr>\n

\"wave\"<\/a><\/td>\nVEGA 2\/0121\/19
\nDominantn\u00e9 mut\u00e1cie u Wolframovho syndr\u00f3mu: potenci\u00e1lne rozdielny mechanizmus \u00fa\u010dinku v porovnan\u00ed s reces\u00edvnymi mut\u00e1ciami<\/i><\/a> (2019 \u2013 2022)
\nVed\u00faci projektu: Michal Cagalinec<\/a><\/td>\n<\/tr>\n
\"wave\"<\/a><\/td>\nVEGA 2\/0091\/19
\nMechanizmy adapt\u00e1cie kostrov\u00e9ho svalu pacientov s chronick\u00fdm metabolick\u00fdm a z\u00e1palov\u00fdm ochoren\u00edm na pravideln\u00e9 cvi\u010denie<\/i><\/a> (2019 \u2013 2022)
\nVed\u00faci projektu: Marta Novotov\u00e1<\/a><\/td>\n<\/tr>\n
\"wave\"<\/a><\/td>\nVEGA 2\/0143\/17
\nDiastolick\u00e1 funkcia ryanod\u00ednov\u00e9ho receptora a tvorba arytmog\u00e9nnych v\u00e1pnikov\u00fdch v\u013an<\/i><\/a> (2017 \u2013 2019)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1<\/a> (2017), Alexandra Zahradn\u00edkov\u00e1, ml.<\/a> (2018-2019)<\/td>\n<\/tr>\n
\"mito\"<\/a><\/td>\nVEGA 2\/0169\/16
\nDynamika a morfol\u00f3gia mitochondri\u00ed u transg\u00e9nneho modelu Wolframovho
\nsyndr\u00f3mu: v\u00fdznam pre ochranu srdca<\/i><\/a> (2016 \u2013 2018)
\nVed\u00faci projektu: Michal Cagalinec<\/a><\/td>\n<\/tr>\n
\"membranes\"<\/a><\/td>\nVEGA 2\/0110\/15
\nVplyv z\u00e1\u0165a\u017ee myokardu na distrib\u00faciu vn\u00fatorn\u00e9ho membr\u00e1nov\u00e9ho syst\u00e9mu srdcov\u00fdch myocytov<\/i><\/a> (2015 \u2013 2017)
\nVed\u00faci projektu: Marta Novotov\u00e1<\/a><\/td>\n<\/tr>\n
\"twocolor\"<\/a><\/td>\nVEGA 2\/0095\/15
\nExpresia a kolokaliz\u00e1cia prote\u00ednov diadick\u00fdch komplexov komorov\u00fdch myocytov potkana vo vz\u0165ahu k ontogen\u00e9ze v\u00e4zby excit\u00e1cie s kontrakciou<\/i><\/a> (2015 \u2013 2017)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1 ml.<\/a>.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

2012-2016<\/h2>\n\n\n\n\n\n\n
<\/td>\n\n

Agent\u00fara na podporu v\u00fdskumu a v\u00fdvoja (APVV):<\/h3>\n<\/td>\n<\/tr>\n

\"image\"<\/a><\/td>\nAPVV-0721-10
\nRemodelovanie myokardu – \u00faloha v\u00e1pnikovej signaliz\u00e1cie (REMOD)<\/a> <\/i>(2011 \u2013 2014)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1<\/a><\/td>\n<\/tr>\n
\"mito3\"<\/a><\/td>\nAPVV-SK-FR-0021-11
\nEnergetick\u00e1 v\u00fdmena a cytoarchitekt\u00fara srdcov\u00fdch svalov\u00fdch buniek. \u00daloha mitochondri\u00e1lneho prote\u00ednu OPA1 <\/i><\/a>(2012 \u2013 2013)
\nVed\u00faci projektu: Marta Novotov\u00e1<\/a><\/td>\n<\/tr>\n
\"APVV4b\"<\/a><\/td>\nAPVV-LPP-0441-09
\nMechanizmy zlyhania funkcie ryanod\u00ednov\u00e9ho receptora<\/i><\/a> (2009 \u2013 2012)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n
<\/td>\n\n

Vedeck\u00e1 grantov\u00e1 agent\u00fara M\u0160VVa\u0160 a SAV (VEGA):<\/h3>\n<\/td>\n<\/tr>\n

\"molecule\"<\/a><\/td>\nVEGA 2\/0148\/14
\nVz\u0165ahy medzi \u0161trukt\u00farou a funkciou ryanod\u00ednov\u00e9ho receptora <\/i><\/a> (2014-2016)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1<\/a><\/td>\n<\/tr>\n
\"image\"<\/a><\/td>\nVEGA 2\/0147\/14
\nV\u00fdvoj diadickej v\u00e1pnikovej signaliz\u00e1cie v priebehu postnat\u00e1lneho v\u00fdvoja ventrikul\u00e1rnych myocytov<\/i><\/a> (2014-2016)
\nVed\u00faci projektu: Ivan Zahradn\u00edk<\/a><\/td>\n<\/tr>\n
<\/a><\/td>\nVEGA 2\/0116\/12
\nPlasticita membr\u00e1nov\u00fdch syst\u00e9mov srdcov\u00fdch myocytov<\/i><\/a> (2012 \u2013 2014)
\nVed\u00faci projektu: Marta Novotov\u00e1<\/a><\/td>\n<\/tr>\n
\"conductance\"<\/a><\/td>\nVEGA 2\/0203\/11
\nDynamika sarkolemy a membr\u00e1novej i\u00f3novej vodivosti srdcov\u00fdch svalov\u00fdch buniek<\/i><\/a> (2011 \u2013 2013)
\nVed\u00faci projektu: Ivan Zahradn\u00edk<\/a><\/td>\n<\/tr>\n
\"image\"<\/a><\/td>\nVEGA 2\/0197\/11
\nMechanizmy komunik\u00e1cie medzi i\u00f3nov\u00fdmi kan\u00e1lmi di\u00e1dy kardiomyocytu<\/i><\/a> (2011 \u2013 2013)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1 ml.<\/a>, Jana Pavelkov\u00e1<\/a><\/td>\n<\/tr>\n
\"wave\"<\/a><\/td>\nVEGA 2\/0190\/10
\nMechanizmy regul\u00e1cie diastolickej aktivity ryanod\u00ednov\u00e9ho receptora<\/i><\/a> (2010 \u2013 2012)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Vybran\u00e9 star\u0161ie projekty<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
<\/td>\n\n

Zahrani\u010dn\u00e9\/medzin\u00e1rodn\u00e9 granty:<\/h3>\n<\/td>\n<\/tr>\n

\"image\"<\/a><\/td>\nLSHM-CT-2005-018833
\nEUGeneHeart: Genomika signaliz\u00e1cie kardiomyocytov v lie\u010den\u00ed a prevenci\u00ed zlyh\u00e1vaj\u00faceho srdca <\/i><\/a>(2006-2010)
\nKoordin\u00e1tor: Gerd Hasenfuss; Ved\u00faci skupiny: Alexandra Zahradn\u00edkov\u00e1<\/a><\/td>\n<\/tr>\n
\"wave\"<\/a><\/td>\nLSHM-CT-2005-018802
\nCONTICA: Kontrola vn\u00fatrobunkov\u00e9ho v\u00e1pnika a arytmie<\/a> <\/i>(2006-2009)
\nKoordin\u00e1tor: Burkert Pieske, University of G\u00f6ttingen \/ University of Graz
\nVed\u00faci skupiny: Alexandra Zahradn\u00edkov\u00e1<\/a><\/td>\n<\/tr>\n
\"wave\"<\/a><\/td>\nNIH FIRCA RO3 TW005543\/2
\nReorganiz\u00e1cia v\u00e1pnikovej signaliz\u00e1cie v zlyh\u00e1vaj\u00facom srdci<\/i> <\/a>(2005-2008)
\nVed\u00faci projektu: Sandor Gyorke, Ohio State University, Columbus, OH, USA
\nMedzin\u00e1rodn\u00fd spolupracovn\u00edk: Alexandra Zahradn\u00edkov\u00e1<\/a>, Ivan Zahradn\u00edk<\/a><\/td>\n<\/tr>\n
\"image\"<\/a><\/td>\nNIH FIRCA RO3 TW005543\/1
\nV\u00e1pnikov\u00e1 signaliz\u00e1cia v srdcovej v\u00e4zbe excit\u00e1cie s kontrakciou<\/i><\/a> (2001-2004)
\nVed\u00faci projektu: Sandor Gyorke, Texas Tech University, Lubbock, TX, USA
\nMedzin\u00e1rodn\u00fd spolupracovn\u00edk: Alexandra Zahradn\u00edkov\u00e1<\/a>, Ivan Zahradn\u00edk<\/a><\/td>\n<\/tr>\n
\"image\"<\/a><\/td>\nHHMI-55000343
\nMolekul\u00e1rny mechanizmus v\u00e1pnikovej signaliz\u00e1cie a v\u00e4zba excit\u00e1cie s kontrakciou na srdci<\/i><\/a> (2001-2005)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1<\/a><\/td>\n<\/tr>\n
\"APVV4b\"<\/a><\/td>\nHHMI-75195547801
\nRyanod\u00ednov\u00fd receptor a v\u00e4zba excit\u00e1cie s kontrakciou<\/i><\/a> (1995-2000)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1<\/a><\/td>\n<\/tr>\n
<\/td>\n\n

Agent\u00fara na podporu v\u00fdskumu a v\u00fdvoja (APVV):<\/h3>\n<\/td>\n<\/tr>\n

\"myo\"<\/a><\/td>\nAPVV-SK-CZ-0172-09
\nBunkov\u00e1 a molekul\u00e1rna fyziol\u00f3gia kardiomyocytov<\/i><\/a> (2010 \u2013 2011)
\nVed\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1<\/a><\/td>\n<\/tr>\n
\"RyR\"<\/a><\/td>\nAPVV-0139-06
\nSaFRyR: SaFRyR: Vz\u0165ah medzi \u0161trukt\u00farou a funkciou dom\u00e9n ryanod\u00ednov\u00e9ho receptora, zodpovedn\u00fdch za CPVT arytmie<\/i><\/a> (2007 \u2013 2009)
\nVed\u00faci projektu: Jozef \u0160ev\u010d\u00edk<\/td>\n<\/tr>\n
\"image\"<\/a><\/td>\nAPVT-51-031104
\nMechanizmus v\u00e4zby excit\u00e1cie s kontrakciou v norm\u00e1lnom a zlyh\u00e1vaj\u00facom myokarde cicavcov <\/i><\/a>(2005 \u2013 2007)
\nVed\u00faci projektu: Ivan Zahradn\u00edk<\/a><\/td>\n<\/tr>\n<\/tr>\n
<\/td>\n\n

In\u00e9 granty:<\/h3>\n<\/td>\n<\/tr>\n

<\/td>\n\u201e\u0160tef\u00e1nik\u201c \u2013 \u010d. 11
\nBunkov\u00e1 architekt\u00fara a prenos energie v srdcov\u00fdch a kostrov\u00fdch svalov\u00fdch bunk\u00e1ch <\/i> (2004 – 2005)
\nVed\u00faci projektu: Marta Novotov\u00e1<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

ERA-CVD_JTC2019-055 HF-MetaB – Metabolick\u00e1 terapia srdcov\u00e9ho zlyhania: \u00faloha vitam\u00ednov B (2020 \u2013 2024) Ved\u00faci projektu: Alexandra Zahradn\u00edkov\u00e1 ml. 2017-2022 Zahrani\u010dn\u00e9\/medzin\u00e1rodn\u00e9 granty: European Joint Program for…\u010d\u00edta\u0165 \u010falej »<\/a><\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":21,"menu_order":20,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/confolab.sav.sk\/ovsb\/wp-json\/wp\/v2\/pages\/117"}],"collection":[{"href":"https:\/\/confolab.sav.sk\/ovsb\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/confolab.sav.sk\/ovsb\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/confolab.sav.sk\/ovsb\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/confolab.sav.sk\/ovsb\/wp-json\/wp\/v2\/comments?post=117"}],"version-history":[{"count":70,"href":"https:\/\/confolab.sav.sk\/ovsb\/wp-json\/wp\/v2\/pages\/117\/revisions"}],"predecessor-version":[{"id":1281,"href":"https:\/\/confolab.sav.sk\/ovsb\/wp-json\/wp\/v2\/pages\/117\/revisions\/1281"}],"up":[{"embeddable":true,"href":"https:\/\/confolab.sav.sk\/ovsb\/wp-json\/wp\/v2\/pages\/21"}],"wp:attachment":[{"href":"https:\/\/confolab.sav.sk\/ovsb\/wp-json\/wp\/v2\/media?parent=117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}